One limitation of this study is that we have only studied the transgenic mice using the TNBS model, a T cell-driven colitis model resembling human CD34, but other experimental colitis models that are also commonly used in IBD research have not been tested for the RenTg mice. The gene discussed is CD34; the disease is colitis.